JOURNEY MEDICAL CORPORATION - COMMON STOCK

Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

23 1 2025 07:30:42 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

12 11 2024 15:01:12 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

04 11 2024 06:00:53 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

25 10 2024 07:30:35 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

03 10 2024 07:30:23 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

09 9 2024 07:30:35 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

04 9 2024 07:15:03 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

12 8 2024 15:01:35 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

06 8 2024 15:01:38 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

11 7 2024 15:05:39 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

15 5 2024 15:01:52 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

13 5 2024 15:01:47 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

07 5 2024 07:30:10 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

01 5 2024 15:01:30 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

25 4 2024 07:30:48 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

21 3 2024 15:01:27 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

18 3 2024 07:30:30 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

15 3 2024 07:30:01 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

13 3 2024 07:30:14 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

05 1 2024 07:30:12 提供 Nasdaq GlobeNewswire